feed,title,long_url,short_url
Benzinga,Fulcrum Therapeutics Announces Preclinical Proof-of-Concept Data for FTX-6058 at the Virtual 14th Annual Sickle Cell Disease Research & Educational Symposium and 43rd National Sickle Cell Disease Scientific Meeting,https://www.benzinga.com/pressreleases/20/09/g17662011/fulcrum-therapeutics-announces-preclinical-proof-of-concept-data-for-ftx-6058-at-the-virtual-14th-,https://j.mp/2FQQ37d
